← Back to Patent Explorer
US5521154A Expired / Lapsed US ⏱️ 0.0 years remaining

Imidoester cross-linked hemoglobin compositions

Assignee: Pharmacia and Upjohn Co
•
Filing: 1994-06-15
•
Granted: 1996-05-28
•
Expires: 2014-06-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An imidoester, cross-linked hemoglobin composition useful in the transport of oxygen to living cells and being essentially free of any impurities, a P50 of at least 13mm Hg and predominantly in tetraruer form. Preferably, the cross-linked hemoglobin composition has a predominant molecular weight of at least 64,000. The purified and cross-linked hemoglobin has improved cross-link stability to autoxidation and can be used as a blood substitute for mammals or as an oxygen transport fluid.

Inventors

  • 👤 Robert L. Garlick
  • 👤 Joseph P. Martin, Jr.
  • 👤 Stephen B. Lyle

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:39
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/795; C07K14/805; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 81 words
A cross-linked hemoglobin for transporting oxygen in living cells having a P50 of at least 13 and wherein at least 80% of said hemoglobin has a molecular weight of at least 64,000 made by the process comprising: cross-linking a deoxygenated hemoglobin lysate with dimethyl adipimidate or dimethyl suberimidate in a polymerization solution having a pH of at least 8 and comprising 50 nM Tris-HCl, NaCl and a buffer selected from the group consisting of 2-amino-2-methyl-1-propanol, Tris, sodium carbonate, CHES and CAPSO.
Claim 2
Dependent Claim 81 words
A cross-linked hemoglobin for transporting oxygen in living cells having a P50 of at least 13 and wherein at least 80% of said hemoglobin has a molecular weight of at least 64,000 made by the process comprising: cross-linking a deoxygenated hemoglobin lysate with dimethyl adipimidate or dimethyl suberimidate in a polymerization solution having a pH of at least 8 and comprising 50 nM Tris-HCl, NaCl and a buffer selected from the group consisting of 2-amino-2-methyl-1-propanol, Tris, sodium carbonate, CHES and CAPSO.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-05-28 1999-11-27 2000-05-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-05-28 2003-11-27 2004-05-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-05-28 2007-11-27 2008-05-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag